v3.25.4
Condensed Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash Flows from Operating Activities    
Net Loss $ (1,374,814) $ (2,029,682)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 128,180 231,210
Stock-based compensation expense 144,504 106,435
Changes in operating assets and liabilities which used cash:    
Accounts receivable (856) 30,060
Prepaid expenses and other current assets (65,057) 232,994
Accounts payable (521) 95,878
Accrued compensation 205,575 30,090
Deferred revenue (20,620) 15,925
Other accrued liabilities (53,240) (51,621)
Net cash and cash equivalents used in operating activities (1,036,849) (1,338,711)
Cash Flows from Investing Activities    
Investment in capitalized software (131,200) (212,599)
Net cash and cash equivalents used in investing activities (131,200) (212,599)
Net decrease in cash, cash equivalents, and restricted cash (1,168,049) (1,551,310)
Cash, cash equivalents, and restricted cash - Beginning of period 2,433,418 2,171,016
Cash, cash equivalents, and restricted cash - End of period 1,265,369 619,706
SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING ACTIVITIES:    
Issuance of common stock for public offering consulting expenses $ 655,000

Source